相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database
Peter C. Taylor et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
Farzin Khosrow-Khavar et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Risk of herpesvirus, and serious and opportunistic infections in atopic dermatitis: population-based cohort study
[Anonymous]
BRITISH JOURNAL OF DERMATOLOGY (2022)
Recent issues in JAK inhibitor safety: perspective for the clinician
Roy Fleischmann
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)
The infection risks of JAK inhibition
Maryam A. Adas et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Steven R. Ytterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort
Yuki M. F. Andersen et al.
BMJ OPEN (2022)
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
E. Wesley Ely et al.
LANCET RESPIRATORY MEDICINE (2022)
Association Between Atopic Dermatitis, Asthma, and Serum Lipids: A UK Biobank Based Observational Study and Mendelian Randomization Analysis
Zhenwei Tang et al.
FRONTIERS IN MEDICINE (2022)
Association between atopic dermatitis and hypertension: a systematic review and meta-analysis
M. Yousaf et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)
Thomas Bieber et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES
E. F. Morand et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani et al.
LANCET (2022)
Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study
J. Wan et al.
BRITISH JOURNAL OF DERMATOLOGY (2022)
The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States
Robin K. Dore et al.
ACR OPEN RHEUMATOLOGY (2022)
Association of inflammatory skin diseases with venous thromboembolism in US adults
Mohammed S. Shaheen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)
Microvascular dysfunction in COVID-19: the MYSTIC study
Alexandros Rovas et al.
ANGIOGENESIS (2021)
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study
Lingyi Li et al.
RHEUMATOLOGY (2021)
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
Jonathan T. Sims et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials
T. Bieber et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis
Jose Maria Pego-Reigosa et al.
RHEUMATOLOGY (2021)
Hematological Manifestations among Patients with Rheumatic Diseases
Alina Klein et al.
ACTA HAEMATOLOGICA (2021)
Comorbidities of alopecia areata: a population-based cohort study
A. Egeberg et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)
Risk of venous thromboembolism in rheumatoid arthritis
Chahinez Ketfi et al.
JOINT BONE SPINE (2021)
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study
Marjolein de Bruin-Weller et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
COVID-19 and thrombosis: From bench to bedside
Mohammad A. M. Ali et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2021)
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
Brett King et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Thrombosis and Coagulopathy in COVID-19
Juan Esteban Gomez-Mesa et al.
CURRENT PROBLEMS IN CARDIOLOGY (2021)
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
Arthur Kavanaugh et al.
JOURNAL OF RHEUMATOLOGY (2021)
Baricitinib in patients with moderate-tosevere atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis
Ann E. Clarke et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
Athimalaipet Ramanan et al.
TRIALS (2021)
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review
Peter C. Taylor et al.
JOURNAL OF CLINICAL MEDICINE (2021)
High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete
Irini Gergianaki et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral
Alexander Egeberg et al.
DERMATOLOGY AND THERAPY (2021)
Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series
Matthew Harries et al.
BMJ OPEN (2021)
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response
Axel P. Villani et al.
ALLERGY (2021)
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
Brett King et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)
Alopecia areata is not a risk factor for heart diseases: A 10-year retrospective cohort study
Heera Lee et al.
PLOS ONE (2021)
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database
Kristin J. Meyers et al.
DERMATOLOGY AND THERAPY (2021)
27523 Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis (AD) from the phase 2 and phase 3 clinical trial program
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
26585 Baricitinib for the treatment of pediatric patients with moderate-to-severe atopic dermatitis
Amy Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases
Maria C. Schneeweiss et al.
JAMA DERMATOLOGY (2021)
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Shahin Shams et al.
FRONTIERS IN PHARMACOLOGY (2021)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial
Vincent C. Marconi et al.
LANCET RESPIRATORY MEDICINE (2021)
COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on Two-Path Unifying Theory of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy
Jae C. Chang
VASCULAR HEALTH AND RISK MANAGEMENT (2021)
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
Stanley B. Cohen et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents
Federico Carbone et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
ARTHRITIS CARE & RESEARCH (2020)
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study
Rabia Agca et al.
JOURNAL OF RHEUMATOLOGY (2020)
Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial
Jon T. Giles et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients
M. Seegraeber et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany
A. Heratizadeh et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials
E. L. Simpson et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Eczema Herpeticum: Clinical and Pathophysiological Aspects
Alexia Damour et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Association of Atopic Dermatitis With Bacterial, Fungal, Viral, and Sexually Transmitted Skin Infections
Ziyou Ren et al.
DERMATITIS (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Risk Factors for Herpes Zoster Infection: A Meta-Analysis
Fawziah Marra et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Mechanism of baricitinib supports artificial intelligence-predicted testing inCOVID-19 patients
Justin Stebbing et al.
EMBO MOLECULAR MEDICINE (2020)
Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis A Systematic Review and Meta-analysis
Lily Wang et al.
JAMA DERMATOLOGY (2020)
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
Kevin L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
Yuya Fujita et al.
BMC IMMUNOLOGY (2020)
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
Maryam M. Asgari et al.
JAMA DERMATOLOGY (2020)
Association Between Atopic Eczema and Cancer in England and Denmark
Kathryn E. Mansfield et al.
JAMA DERMATOLOGY (2020)
Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome
Adeline Vanderver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis A Randomized Clinical Trial
Kristian Reich et al.
JAMA DERMATOLOGY (2020)
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
Stanley B. Cohen et al.
RMD OPEN (2020)
Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib
Jonathan Kay et al.
RMD OPEN (2020)
Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases
Zoltan Szekanece et al.
AUTOIMMUNITY REVIEWS (2020)
Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment
Annette de Thurah et al.
RMD OPEN (2020)
Comorbidities in alopecia areata: A systematic review and meta-analysis
Solam Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study
Seoyoung C. Kim et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials
Wenhui Xie et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions
Aleksandra Korniluk et al.
MEDIATORS OF INFLAMMATION (2019)
Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients
Gregory Katz et al.
MAYO CLINIC PROCEEDINGS (2019)
Association between atopic dermatitis and extracutaneous bacterial and mycobacterial infections: A systematic review and meta-analysis
Linda Serrano et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Clinical significance of Janus Kinase inhibitor selectivity
Ernest H. Choy
RHEUMATOLOGY (2019)
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis
Peter C. Taylor et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
Bella Mehta et al.
RMD OPEN (2019)
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
Iain B. McInnes et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
Huifang Liang et al.
RMD OPEN (2019)
Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study
Alexis Ogdie et al.
EUROPEAN HEART JOURNAL (2018)
Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective
Masayoshi Harigai
MODERN RHEUMATOLOGY (2018)
Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults
Shanthi Narla et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies
Peter C. Taylor et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations
J. P. Thyssen et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Pathogenesis and diagnosis of disseminated intravascular coagulation
M. Levi
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2018)
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Daniel J. Wallace et al.
LANCET (2018)
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis
Roxanne Cooksey et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis
Kim Lauper et al.
ARTHRITIS CARE & RESEARCH (2018)
Cancer risk by the subtype of alopecia
Ji Hyun Lee et al.
SCIENTIFIC REPORTS (2018)
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study
Richard J. Silverwood et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study
Richard J. Silverwood et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study
Chih-Chiang Chen et al.
CANCER MEDICINE (2018)
Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders
Amy Paller et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
Relationship of atopic dermatitis with stroke and myocardial infarction A meta-analysis
Min Yuan et al.
MEDICINE (2018)
Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis
A. Egeberg et al.
ALLERGY (2017)
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
A. Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
Jonas K. Eriksson et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study
J. Halskou Hesselvig et al.
LUPUS (2017)
Association of Atopic Dermatitis with Cardiovascular Risk Factors and Diseases
Marie Standl et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
Patrick M. Brunner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
JAK inhibitors in dermatology: The promise of a new drug class
William Damsky et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study
O. Ahlehoff et al.
LUPUS (2017)
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Peter C. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study
Kensuke Kume et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study
J. Antonio Avina-Zubieta et al.
ARTHRITIS CARE & RESEARCH (2017)
Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice A Nationwide Cohort Study From Sweden
Hjalmar Wadstroem et al.
JAMA INTERNAL MEDICINE (2017)
Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Medha Barbhaiya et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Roy Fleischmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin
Leila N. Varghese et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
A review on SLE and malignancy
May Y. Choi et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2017)
Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis
Katelynn M. Wilton et al.
RHEUMATOLOGY AND THERAPY (2017)
Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice
Zaicun Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
Yuki M. F. Andersen et al.
CURRENT DERMATOLOGY REPORTS (2017)
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
Johan Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Daniella M. Schwartz et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Reduced incidence of skin cancer in patients with alopecia areata: A retrospective cohort study
Arash Mostaghimi et al.
CANCER EPIDEMIOLOGY (2016)
Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis
Yuki M. F. Andersen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis
Sara Gandini et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
Yoshiya Tanaka et al.
JOURNAL OF RHEUMATOLOGY (2016)
Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis
Kathie P. Huang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Baricitinib in Patients with Refractory Rheumatoid Arthritis
Mark C. Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Dyslipidemia in systemic lupus erythematosus: just another comorbidity?
Konstantinos Tselios et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor
Christina Charles-Schoeman et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study
Jette Lindorff Riis et al.
BMJ OPEN (2016)
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases Implications for Vaccination
Huifeng Yun et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
Andrea Rubbert-Roth et al.
RMD OPEN (2016)
Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs
Seoyoung C. Kim et al.
AMERICAN JOURNAL OF MEDICINE (2015)
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Camille Roubille et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Malignancies in systemic lupus erythematosus: a 2015 update
Gillian C. Goobie et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Management of neutropenia in patients with rheumatoid arthritis
Estibaliz Lazaro et al.
JOINT BONE SPINE (2015)
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
Florence J. Dalgard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative
Camille Roubille et al.
JOURNAL OF RHEUMATOLOGY (2015)
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis
Laureline Legendre et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Epidemiology of venous thromboembolism
John A. Heit
NATURE REVIEWS CARDIOLOGY (2015)
The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study
J. Antonio Avina-Zubieta et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees
Hussain R. Yusuf et al.
THROMBOSIS RESEARCH (2015)
Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
Jiunn-Horng Kang et al.
SCIENTIFIC REPORTS (2015)
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
Edward C. Keystone et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis
Patompong Ungprasert et al.
RHEUMATOLOGY (2015)
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
Teresa A. Simon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions
Hanna Johnsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990-2009
Sultan A. Mirzoyev et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study
W. -S. Chung et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases
Jason J. Lee et al.
ARTHRITIS RESEARCH & THERAPY (2014)
A Comparison of the Malignancy Incidence Among Patients With Psoriatic Arthritis and Patients With Rheumatoid Arthritis in a Large US Cohort
Rachael L. Gross et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
Kevin L. Winthrop et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study
Hyon K. Choi et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Mechanisms of Premature Atherosclerosis in Rheumatoid Arthritis and Lupus
J. Michelle Kahlenberg et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Mental health comorbidity in patients with atopic dermatitis
Pouya Yaghmaie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
A. Danza et al.
LUPUS (2013)
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
Joachim Listing et al.
RHEUMATOLOGY (2013)
Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis
Seoyoung C. Kim et al.
ARTHRITIS CARE & RESEARCH (2013)
Autoimmune, Atopic, and Mental Health Comorbid Conditions Associated With Alopecia Areata in the United States
Kathie P. Huang et al.
JAMA DERMATOLOGY (2013)
Atopic Dermatitis and Risk of Skin Cancer A Danish Nationwide Cohort Study (1977-2006)
Annette O. Jensen et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Juan Antonio Avina-Zubieta et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?
A. Kirstin Bacani et al.
ARTHRITIS AND RHEUMATISM (2012)
Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization
Marie E. Holmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study
S. A. Johannesdottir et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Targeting Cancer with a Lupus Autoantibody
James E. Hansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis
Jeffrey R. Curtis et al.
ARTHRITIS CARE & RESEARCH (2012)
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
Rebecca Davies et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Longitudinal Predictors of Progression of Carotid Atherosclerosis in Rheumatoid Arthritis
Jon T. Giles et al.
ARTHRITIS AND RHEUMATISM (2011)
Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
Taras Gout et al.
CLINICAL RHEUMATOLOGY (2011)
Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention
Maureen McMahon et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response
Donald Y. M. Leung et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease
Carlos Gonzalez-Juanatey et al.
ARTHRITIS RESEARCH & THERAPY (2011)
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
Tao Zheng et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2011)
Is the Incidence of Rheumatoid Arthritis Rising? Results From Olmsted County, Minnesota, 1955-2007
Elena Myasoedova et al.
ARTHRITIS AND RHEUMATISM (2010)
Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K.
A. Arana et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
Jordan S. Fridman et al.
JOURNAL OF IMMUNOLOGY (2010)
A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract
Francis K. L. Chan et al.
JOURNAL OF RHEUMATOLOGY (2010)
Mean platelet volume is a risk factor for venous thromboembolism: the Troms circle divide study
S. K. Braekkan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
E. Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum
Lisa A. Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Atopic Dermatitis: A Disease Caused by Innate Immune Defects?
Anna De Benedetto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Thrombosis in Systemic Lupus Erythematosus and Other Autoimmune Diseases of Recent Onset
Juanita Romero-Diaz et al.
JOURNAL OF RHEUMATOLOGY (2009)
DMARDS and infections in rheumatoid arthritis
Roberto Caporali et al.
AUTOIMMUNITY REVIEWS (2008)
Incidence of perforated diverticulitis and risk factors for death in a UK population
C. R. Morris et al.
BRITISH JOURNAL OF SURGERY (2008)
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus
Mary J. Roman et al.
ARTHRITIS AND RHEUMATISM (2007)
Atopic dermatitis and cancer risk
H Wang et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
The epidemiology of venous thromboembolism
RH White
CIRCULATION (2003)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Predictors of infection in rheumatoid arthritis
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)